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Abstract
Background: Although therapeutic concepts of patients with major trauma have improved during
recent years, organ dysfunction still remains a frequent complication during clinical course in
intensive care units. It has previously been shown that cytokines are upregulated under stress
conditions such as trauma or sepsis. However, it is still debatable if cytokines are adequate
parameters to describe the current state of trauma patients. To elucidate the relevance of
cytokines, we investigated if cytokines predict development of multiple organ dysfunction
syndrome (MODS) or outcome.
Methods: A total of 143 patients with an injury severity score ≥ 16, between 16 and 65 years,
admitted to the Hannover Medical School Level 1 Trauma Center between January 1997 and
December 2001 were prospectively included in this study. Marshall Score for MODS was calculated
for at least 14 days and plasma levels of TNF-α, IL-1β, IL-6, IL-8 and IL-10 were measured. To
determine the association between cytokine levels and development of MODS the Spearman rank
correlation coefficient was calculated and logistic regression and analysis were performed.
Results and Discussion: Patients with MODS had increased plasma levels of IL-6, IL-8 and IL-10.
IL-6 predicted development of MODS with an overall accuracy of 84.7% (specificity: 98.3%,
sensitivity: 16.7%). The threshold value for development of MODS was 761.7 pg/ml and 2176.0 pg/
ml for mortality during the in patient time.
Conclusion: We conclude that plasma IL-6 levels predict mortality and that they are a useful tool
to identify patients who are at risk for development of MODS.
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Background
During the last decades, improvement of therapeutic con-
cepts has decreased trauma related fatalities [1]. Organ
dysfunction is still a frequent and severe complication
during clinical course and the most common cause for
late fatalities following major trauma. Although the sur-
vival rate of patients with multiple injuries improved dur-
ing the last decades the frequency of development of
organ dysfunction has not changed [2,3]. The mortality of
patients developing multiple organ dysfunction syn-
drome (MODS) following severe injuries is still 50% [4-
6]. For adequate treatment, it would be desirable to iden-
tify patients with a high risk for posttraumatic complica-
tions in the early clinical course. The evaluation of clinical
state and prognosis still remains one of the greatest chal-
lenges during treatment of patients suffering from multi-
ple injuries. Many clinical parameters such as blood
pressure, pH or heart rate failed to assess the posttrau-
matic situation [7].
Several clinical studies have demonstrated that increased
cytokine plasma levels are correlated with MODS, severity
of injury, as well as mortality [8-13]. While plasma IL-6
levels were able to predict outcome in a murine sepsis
model [14], the data in humans is still controversial
[12,15-17]. Thus, it was the purpose of our study to corre-
late plasma cytokine levels with MODS and mortality and
determine threshold values of these cytokines for develop-
ment of MODS. We hypothesized that plasma cytokines
levels can predict MODS and mortality in humans follow-
ing major trauma. To test this hypothesis we correlated
plasma levels of IL-1β, IL-6, IL-8, IL-10 and TNF-α as well
as traditional parameters such as lactate, platelets and
base excess with MODS and mortality.
Methods
Inclusion and exclusion criteria
Polytraumatized patients between the ages of 16 and 65
years who were admitted to Hannover Medical School
Level 1 Trauma Center between January 1997 and Decem-
ber 2001 were prospectively included in this study.
Patients with an injury severity score <16 points were
excluded. In addition, patients with a history of steroid
use, anti-inflammatory treatment or hormone replace-
ment therapy were excluded. Patients with malignancies
or chronic diseases of the liver, kidneys or lung were also
excluded (Table 1).
Ethical approval and informed consent
The study was approved by the Ethical Committee of the
Hannover Medical School, Hannover, Germany.
Informed consent was obtained from all patients (or their
relatives) included in this study.
Pattern and severity of injury
Additionally, the abbreviated injury scale was determined
after a trauma scan (CT scan of head, cervical spine, tho-
rax, abdomen and pelvis) and severity of injury was calcu-
lated using the injury severity score (ISS).
Clinical parameter and outcome evaluation
Patients were carefully examined at 7 AM and blood (10
ml) was daily collected for routine analysis and cytokine
measurement (TNF-α, IL-1β, IL-6, IL-8, IL-10). Plasma
cytokines were determined using a commercially availa-
ble kit (Immulite® System: Random Access Immunoassay
Analyser; DPC-Biermann, Bad Nauheim, Germany) fol-
lowing the manufacturer's instructions. The results of clin-
ical examination and blood chemistry (C-reactive protein
[CRP], platelets, lactate and base excess) were recorded up
to 14 days after admission (Table 2).
Diagnosis of sepsis was made according to the criteria of
the Consensus Conference of the American College of Chest
Physicians (ACCP) and the Society of Critical Care Medicine
(SCCM) [18] on at least two consecutive days [19]. MODS
was diagnosed using the score of Marshall et al [20]. This
score has been shown to be the most reliable score for
diagnosis of MODS [21]. As previously described, a man-
ifest MODS was considered when the score was >12
points on two consecutive days or at least three days dur-
ing the observed period [22].
Table 1: Demographic data of included patients; *p < 0.05 MODS 
vs. No MODS.
Parameter MODS No MODS All patients
Patients [n] 24 119 143
Age [years] 40.0 ± 3.6 36.3 ± 1.4 36.9 ± 1.3
Sex [m:f] 7:1* 2.5:1 2.9:1
GCS 9.0 ± 1.0 10.5 ± 0.5 10.2 ± 0.4
ISS 28.5 ± 2.1 24.5 ± 0.7 25.1 ± 0.7
Mortality [%] 54.2 6.7 14.7
Table 2: Correlation coefficient of laboratory parameters and 
development of MODS. 
Parameter Correlation coefficient
IL-1β 0.00
IL-6 0.35*
IL-8 0.53*
IL-10 0.31*
TNF-α 0.32*
CRP 0.27*
Platelets -0.32*
Lactate 0.37*
Base Excess 0.11*
* p < 0.01Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 2009, 17:49 http://www.sjtrem.com/content/17/1/49
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Patient management and treatment
After admission, all patients received an arterial and a cen-
tral venous line. A standardized clinical examination, a
focused assessment with sonography for trauma (FAST)
and at least chest and pelvic x-rays were performed. After
diagnostics in the emergency room, a trauma scan (CT-
scan of head, cervical spine, chest, abdomen and pelvis)
was accomplished. Results were analyzed by an attending
radiologist and an attending trauma surgeon. At time of
admission to the intensive care unit (ICU), the clinical
examination and FAST were repeated. Included patients
were treated by physicians who are not involved in this
study.
Subgroup analysis
Depending on fulfillment of the MODS criteria, patients
were divided into two groups, those with and without
multiple organ dysfunction syndrome (MODS, no
MODS).
Statistics
Statistical analysis was performed using SPSS, version 15
(SPSS, Chicago, IL, USA). Results from descriptive analy-
ses are expressed as mean ± standard error of the mean.
Statistical significance was assumed where probability val-
ues p of less than 0.05 were obtained. Comparison
between groups was performed using one-way analysis of
variances (ANOVA) followed by the Tukey test. The Spear-
man rank correlation coefficient was used to determine
the connection between cytokine levels and development
of MODS. Additionally we performed an analysis of the
relationship between the plasma cytokine concentrations
and complications using logistic regression for identifying
relevant parameters as well as a receiver operating charac-
teristic (ROC) curve analysis for validation of Il-6 as a pre-
dictive marker.
Results
Demographics
A total of 143 patients (106 males and 37 females) were
included in this study. Age and ISS were comparable in all
analyzed subgroups. Additional characteristics are shown
in Table 1.
Pattern and severity of injury
Pattern and severity of injury were comparable in all ana-
lyzed groups. Furthermore, injury severity and pattern
described by AIS (abbreviated injury scale; data not
shown) and ISS (Table 1) showed no significant differ-
ence in all analyzed subgroups.
MODS influence on plasma cytokines
TNF-α
While plasma levels of TNF-α were comparable on day 1
in patients with and without MODS, a steady increase was
observed in the MODS group (p < 0.05).
IL-1β
During the observed period, MODS did not influence
plasma levels of IL-1β (p > 0.05).
IL-6
During the entire observation period, patients with
MODS had higher plasma levels of IL-6 than patients
without MODS. Differences were more distinct during the
first week (p < 0.05).
IL-8
Plasma levels of IL-8 were significantly higher in MODS
patients than in patients who did not have MODS with a
distinct difference at day 1 (p < 0.05).
IL-10
MODS patients had increased plasma levels of IL-10 on
days 1 to 3 and days 9 to 14 compared with patients with-
out MODS (p < 0.05).
MODS influence on other plasma parameters
CRP
MODS patients had increased plasma CRP levels on days
4 to 14 (p < 0.05).
Platelets
During the entire observation period, patients with
MODS had higher platelet counts than patients without
MODS (p < 0.05).
Lactate
Patients with organ dysfunction had higher plasma lactate
levels as compared to patients with uneventful recovery
on days 1 to 14 (p < 0.05).
Base excess
Base excess was elevated in patients with MODS on days
2, 3 and 13 (p < 0.05).
Correlation between cytokines and MODS
Besides IL-1β all analyzed cytokines showed a significant
correlation between cytokine plasma concentration and
development of MODS. The correlation coefficients for all
analyzed cytokines are shown in Table 2.
Correlation between laboratory values and MODS
All tested parameters correlated with development of
MODS (see Table 3).Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 2009, 17:49 http://www.sjtrem.com/content/17/1/49
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Sensitivity, specificity and overall accuracy
For all cytokines with a correlation coefficient >0.26, sen-
sitivity, specificity and overall accuracy were calculated.
The sensitivity for IL-8, IL-10, TNF-α, CRP and base excess
was 0%. The specificity of IL-6 was 98.3% while sensitivity
was only 16.7% (overall accuracy 84.7%). Combination
of IL-6 with platelets and lactate improved sensitivity and
specificity (Table 3).
Critical value of IL-6 for MODS development
Since IL-6 was the best parameter for predicting the devel-
opment of posttraumatic MODS we calculated a thresh-
old value at which the probability of MODS development
is >50%. At a plasma IL-6 concentration of 761.7 pg/μl,
>50% patients developed MODS. Injury pattern and
severity is shown in Table 4.
Prognostic value of IL-6 for mortality in the early clinical 
course
At day 1 plasma IL-6 levels had a specificity of 100% while
the sensitivity was 28.6%. The overall accuracy was
86.1%. At day 2, similar values were detected (specificity:
97.8%, sensitivity: 19.0%, overall accuracy: 83.2%) The
IL-6 threshold value for mortality during the in-patient
time was 2176.0 pg/ml.
ROC curve analysis
The ROC curve analysis for IL-6 for predicting MODS and
mortality are shown in Fig. 1. The areas under the curve
for MODS and mortality are, respectively, 0.874 (SE 0.03;
95% confidence interval [CI] 0.8110.937), 0.858 (SE
0.05; 95% CI 0.759-0.956).
Discussion
As previously published, we have investigated the plasma
levels of common parameters (CRP, platelets, lactate and
base excess) and various cytokines such as TNF-α, IL-1β,
IL-6, IL-8, and IL-10 in patients suffering from major
trauma[13] Besides IL-1β, all cytokines showed higher
levels in patients matching the MODS criteria and corre-
lated with MODS. Patients with MODS had no greater
severity of injury or a different injury pattern [13]. IL-6 not
only showed the best correlation but predicted develop-
ment of MODS with an overall accuracy of 84.7%. In
addition, IL-6 was the best parameter in predicting mor-
tality (overall accuracy 86.1% at day 1 and 83.2% at day
2).
The fact that patients with MODS had higher cytokine
plasma levels is consistent with our previously published
results in the same population as well as observations
from other investigators [8,12,13,15,23]. However, to the
best of our knowledge, this is the first study providing a
threshold value of IL-6 for development of organ dysfunc-
tion and mortality.
The authors are aware of the limitations of the present
study due to an inhomogeneous population. There are
several factors influencing systemic cytokine levels (i.e.
number of blood transfusions, gender, genetic polymor-
phisms) that cannot be controlled due to the design of the
study [13,24,25].
Since trauma has a huge socioeconomic impact [26] and
sepsis and MODS increase costs of treatment in trauma
patients [27] it is necessary to identify patients susceptible
for development of MODS in early clinical course to
Table 3: Specifity, sensitivity and accuracy of laboratory markers.
Parameter Specificity Sensitivity Overall accuracy
IL-6 98.3% 16.7% 84.7%*
IL-8 n.d. n.d. n.d.
IL-10 n.d. n.d. n.d.
TNF-α n.d. n.d. n.d.
CRP n.d. n.d. n.d.
Platelets 98.3% 8.3% 83.2%*
Lactate 99.1% 8.7% 83.9%*
Base Excess n.d. n.d. n.d.
IL-6+Lactate 97% 17% 84.7%*
IL-6+Platelets 98% 21% 84.6%*
IL-6+Lactate+Platelets 97% 26% 85.4%*
Table 4: Injury pattern and severity of patients with systemic IL-6 levels above the critical value for the development of MODS.
AIShead/neck AISface AISchest AISabdomen AISExtremity AISsoft tissue ISS
2.8 ± 1.1 0 ± 0 3.5 ± 0.8 3.0 ± 1.3 3.0 ± 0.4 1.0 ± 0.0 28.2 ± 11.9Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 2009, 17:49 http://www.sjtrem.com/content/17/1/49
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adjust therapeutic interventions. The concept of damage
control surgery is based on studies investigating further
damage by operations in the early clinical phase [10].
Though the outcome of patients has improved during
recent years, defined parameters predicting posttraumatic
complications are still lacking.
The present study shows increased plasma IL-6 levels in
patients with MODS as compared to patients with une-
ventful recovery. These findings confirm studies from
other investigators [12,15]. However, in several studies a
correlation between IL-6 and MODS was not proven
[16,17]. Since in both studies only 16 and 13 patients,
respectively, were included lack of a correlation between
plasma IL-6 levels and MODS could be due to the small
number of patients. In the present study, IL-6 was the best
parameter for predicting development of MODS as com-
pared to other cytokines. Since IL-6 had the highest specif-
icity and overall accuracy we calculated a threshold value
above which the development of MODS is likely. This crit-
ical value may be of high relevance in further treatment of
polytraumatized patients. In the present study, we showed
that IL-6 predicts outcome in patients following major
trauma. Thus, we confirmed studies from a murine septic
shock model showing that IL-6 predicts outcome in the
early phase of sepsis [14,28]. In humans, a correlation
between high plasma IL-6 levels and outcome was shown
in pediatric patients with major head injury [29]. Martin
et al. showed that elevated plasma levels were associated
with fatal outcome in septic shock stage [30]. Addition-
ally, increased IL-6 values were an indicator of the devel-
opment of a nosocomial infection in trauma patients.
However, to our knowledge this is the first study describ-
ing a critical value of IL-6 for development of MODS and
predicting mortality.
Patients matching the MODS criteria had higher plasma
IL-8 levels than patients without complications. We could
determine a correlation between systemic IL-8 concentra-
tions and the MODS score. This finding is in accordance
ROC curve analysis of IL-6 for the prediction of MODS (A) and mortality (B) Figure 1
ROC curve analysis of IL-6 for the prediction of MODS (A) and mortality (B).
A B
MODS MortalityScandinavian Journal of Trauma, Resuscitation and Emergency Medicine 2009, 17:49 http://www.sjtrem.com/content/17/1/49
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with data from other investigators who also show an asso-
ciation between organ dysfunction and increased plasma
IL-8 levels in patients with major injury [11]. Further-
more, patients with established diagnosis of adult respira-
tory distress syndrome, a common posttraumatic
complication [31], showed elevated IL-8 levels in bron-
choalveolar lavage fluid [8]. In the performed logistic
regression analysis, we could show a correlation between
MODS and IL-8 levels, but IL-8 was not able to identify
patients suffering from MODS. Thus, IL-8 seems not to be
an adequate parameter regarding the development of
MODS. Since IL-8 showed an association to thoracic
trauma [8,9] its role in this particular injury needs to be
evaluated in further studies.
In the present study patients with MODS had higher IL-10
plasma levels in the early clinical course. Elevated sys-
temic IL-10 levels correlated with MODS but were not of
value predicting the development of organ failure. Nei-
dhard et al. showed that increased plasma IL-10 levels are
not only associated with posttraumatic complications but
also with severity of injury [23]. Since IL-10 is an anti-
inflammatory cytokine, elevated levels can be estimated
as a compensatory anti-inflammatory response to prevent
possible harmful hyperinflammation.
Although IL-10 levels were increased in patients with
MODS, studies have shown that elevated levels may con-
tribute to augmented organ dysfunction in trauma
patients [32]. However, IL-10 failed to predict develop-
ment of organ dysfunction in the present study.
Patients with MODS did not have higher levels of IL-1β as
compared to patients without MODS. This is in accord-
ance with findings from other studies in which IL-1-β was
not increased during response to septic shock secondary
to generalized peritonitis [33]. Contrary to these results,
other investigators proved an association between IL-1β
and with an increased mortality rate and an increased risk
for subsequent ARDS and MOF in patients following
major vascular surgery, trauma or hemorrhagic shock
[12]. These conflicting results may be due to the short
half-life (6 min) of this mediator [34]. However, our
results indicate that IL-1β is not correlated with MODS
and is therefore not a useful parameter for predicting post-
traumatic organ dysfunction.
In the present study, patients suffering from organ dys-
function had increased plasma TNF-α levels as compared
to patients without MODS. Similar results were shown by
other investigators for trauma patients [35], as well as in
burn patients [36]. Although there is an association
between TNF-α and MODS, this pro-inflammatory
cytokine failed to predict development of MODS investi-
gated in the logistic regression analysis.
As previously described, the traditional parameters for
describing the status of patients following trauma or with
major surgery were associated with organ dysfunction
[7,37,38]. Although all investigated parameters failed to
predict mortality or development of MODS, in combina-
tion with IL-6, they improved the sensitivity, specificity
and overall accuracy as compared to IL-6 alone. Although
secretion of CRP is induced by IL-6[39] in the present
study, CRP failed to correlate with the development of
MODS.
Conclusion
In the current study we demonstrated the correlation
between various cytokines and MODS in polytraumatized
patients. We determined a threshold value for IL-6 for pre-
dicting development of MODS and predicting mortality.
This will help to identify patients in the early clinical
period who are susceptible to develop organ dysfunction.
This is important insofar as these patients require special
therapeutic concepts such as damage control surgery.
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